Cargando…
Correcting glucose-6-phosphate dehydrogenase deficiency with a small-molecule activator
Glucose-6-phosphate dehydrogenase (G6PD) deficiency, one of the most common human genetic enzymopathies, is caused by over 160 different point mutations and contributes to the severity of many acute and chronic diseases associated with oxidative stress, including hemolytic anemia and bilirubin-induc...
Autores principales: | Hwang, Sunhee, Mruk, Karen, Rahighi, Simin, Raub, Andrew G., Chen, Che-Hong, Dorn, Lisa E., Horikoshi, Naoki, Wakatsuki, Soichi, Chen, James K., Mochly-Rosen, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168459/ https://www.ncbi.nlm.nih.gov/pubmed/30279493 http://dx.doi.org/10.1038/s41467-018-06447-z |
Ejemplares similares
-
Long-range structural defects by pathogenic mutations in most severe glucose-6-phosphate dehydrogenase deficiency
por: Horikoshi, Naoki, et al.
Publicado: (2021) -
Stabilization of glucose-6-phosphate dehydrogenase oligomers enhances catalytic activity and stability of clinical variants
por: Garcia, Adriana Ann, et al.
Publicado: (2022) -
Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010) -
Impaired GAPDH-induced mitophagy contributes to the pathology of Huntington’s disease
por: Hwang, Sunhee, et al.
Publicado: (2015) -
Aldehyde dehydrogenase 2*2 knock-in mice show increased reactive oxygen species production in response to cisplatin treatment
por: Kim, Jeewon, et al.
Publicado: (2017)